TY - JOUR
T1 - Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study
AU - Cai, Lina
AU - Wheeler, Eleanor
AU - Kerrison, Nicola D.
AU - Luan, Jian’an
AU - Deloukas, Panos
AU - Franks, Paul W.
AU - Amiano, Pilar
AU - Ardanaz, Eva
AU - Bonet, Catalina
AU - Fagherazzi, Guy
AU - Groop, Leif C.
AU - Kaaks, Rudolf
AU - Huerta, José María
AU - Masala, Giovanna
AU - Nilsson, Peter M.
AU - Overvad, Kim
AU - Pala, Valeria
AU - Panico, Salvatore
AU - Rodriguez-Barranco, Miguel
AU - Rolandsson, Olov
AU - Sacerdote, Carlotta
AU - Schulze, Matthias B.
AU - Spijkerman, Annemieke M.W.
AU - Tjonneland, Anne
AU - Tumino, Rosario
AU - van der Schouw, Yvonne T.
AU - Sharp, Stephen J.
AU - Forouhi, Nita G.
AU - Riboli, Elio
AU - McCarthy, Mark I.
AU - Barroso, Inês
AU - Langenberg, Claudia
AU - Wareham, Nicholas J.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Type 2 diabetes (T2D) is a global public health challenge. Whilst the advent of genome-wide association studies has identified >400 genetic variants associated with T2D, our understanding of its biological mechanisms and translational insights is still limited. The EPIC-InterAct project, centred in 8 countries in the European Prospective Investigations into Cancer and Nutrition study, is one of the largest prospective studies of T2D. Established as a nested case-cohort study to investigate the interplay between genetic and lifestyle behavioural factors on the risk of T2D, a total of 12,403 individuals were identified as incident T2D cases, and a representative sub-cohort of 16,154 individuals was selected from a larger cohort of 340,234 participants with a follow-up time of 3.99 million person-years. We describe the results from a genome-wide association analysis between more than 8.9 million SNPs and T2D risk among 22,326 individuals (9,978 cases and 12,348 non-cases) from the EPIC-InterAct study. The summary statistics to be shared provide a valuable resource to facilitate further investigations into the genetics of T2D.
AB - Type 2 diabetes (T2D) is a global public health challenge. Whilst the advent of genome-wide association studies has identified >400 genetic variants associated with T2D, our understanding of its biological mechanisms and translational insights is still limited. The EPIC-InterAct project, centred in 8 countries in the European Prospective Investigations into Cancer and Nutrition study, is one of the largest prospective studies of T2D. Established as a nested case-cohort study to investigate the interplay between genetic and lifestyle behavioural factors on the risk of T2D, a total of 12,403 individuals were identified as incident T2D cases, and a representative sub-cohort of 16,154 individuals was selected from a larger cohort of 340,234 participants with a follow-up time of 3.99 million person-years. We describe the results from a genome-wide association analysis between more than 8.9 million SNPs and T2D risk among 22,326 individuals (9,978 cases and 12,348 non-cases) from the EPIC-InterAct study. The summary statistics to be shared provide a valuable resource to facilitate further investigations into the genetics of T2D.
UR - http://www.scopus.com/inward/record.url?scp=85095940655&partnerID=8YFLogxK
U2 - 10.1038/s41597-020-00716-7
DO - 10.1038/s41597-020-00716-7
M3 - Article
SN - 2052-4463
VL - 7
JO - Scientific data
JF - Scientific data
IS - 1
M1 - 393
ER -